Iminostilbene

CAT:
804-HY-N7064-01
Size:
1 g
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Iminostilbene - image 1

Iminostilbene

  • Description:

    Iminostilbene is a chemical precursor of carbamazepine. Additionally, Iminostilbene is an orally active inhibitor of PKM2 (Pyruvate Kinase M2) and COX2 (Cyclooxygenase-2) . Iminostilbene exerts its effects by inhibiting PKM2 and its interaction with HIF-1α and STAT3, reducing COX2 and iNOS expression, and decreasing LPS-induced release of IL-1β, IL-6, TNF-α, and MCP-1, thereby suppressing macrophage-mediated inflammatory responses and improving myocardial ischemia/reperfusion (MI/R) injury. Iminostilbene holds promise for research in inflammation regulation, cardiovascular diseases (such as MI/R injury), and macrophage-mediated immune-related diseases[1][2].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H401, H411
  • Target:

    COX; HIF/HIF Prolyl-Hydroxylase; Interleukin Related; NO Synthase; Pyruvate Kinase; STAT; TNF Receptor
  • Type:

    Reference compound
  • Related Pathways:

    Apoptosis; Immunology/Inflammation; JAK/STAT Signaling; Metabolic Enzyme/Protease; Stem Cell/Wnt
  • Field of Research:

    Inflammation/Immunology; Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/iminostilbene.html
  • Purity:

    99.34
  • Solubility:

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles:

    C12=CC=CC=C1C=CC3=CC=CC=C3N2
  • Molecular Formula:

    C14H11N
  • Molecular Weight:

    193.25
  • Precautions:

    H302, H401, H411
  • References & Citations:

    [1]Christian P, et al. Crystallization of Carbamazepine in Proximity to Its Precursor Iminostilbene and a Silica Surface. Cryst Growth Des. 2016 May 4;16 (5) :2771-2778. Epub 2016 Mar 30.|[2]Lu S, et al. Iminostilbene, a novel small-molecule modulator of PKM2, suppresses macrophage inflammation in myocardial ischemia-reperfusion injury. J Adv Res. 2020 Sep 9;29:83-94.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, protect from light)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • Isoform:

    COX-2; HIF-1α; iNOS; STAT3
  • CAS Number:

    [256-96-2]